Contacts
Ross McNaughton

Ross McNaughton

Partner

Read More
Alex Dodds

Alex Dodds

Senior associate

Read More
Contacts
Ross McNaughton

Ross McNaughton

Partner

Read More
Alex Dodds

Alex Dodds

Senior associate

Read More

10 February 2021

Investment round for Cambridge quantum computing company

We have advised Cambridge Innovation Capital, Amadeus Capital Partners, Parkwalk and the University of Cambridge on their participation in the $20m fundraise by innovative quantum computing company Riverlane. The investment was made as part of a round led by Draper Esprit.

Riverlane's software transforms quantum computers from experimental technology into commercial products. The company raised the funds to build Deltaflow, the operating system for quantum computers. 

Commenting on the deal, Corporate Technology Partner Ross McNaughton, said: "This deal will allow Riverlane to continue to develop its operating software and transform the way cutting edge quantum technology is commercialised. This deal underlines our strong position in the Cambridge market, working with companies and investors in the deeptech space. We look forward to watching Riverlane go from strength to strength."

Steve Brierley, Founder and CEO of Riverlane, said: "For a quantum ecosystem to thrive, we urgently need an operating system. An operating system makes quantum computers useful – it allows programs and applications to run on many different machines. Riverlane aims to make our operating system Deltaflow a global standard."

The team was led by partner Ross McNaughton and associate Alex Dodds. 

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Hallway in server room
Technology, media & communications

Advising leading underwriting and risk analytics business, Envelop Risk, on its $130 million Series B financing

24 September 2021

by Ross McNaughton and Alex Dodds

Click here to find out more
Office facade reflection
Corporate/M&A & capital markets

Revolutionising access to biology with transformational acquisition by Nuclera

13 May 2021

by Ross McNaughton and Adrian Toutoungi

Click here to find out more
car wheels sets isolated on yellow background
Technology, media & communications

Advising Oxbotica in $47 million Series B investment

15 January 2021

by Ross McNaughton and Matt Harrison

Click here to find out more